ギャンボラ入金不要ボーナス

Corporate Corporate Basic Information Message from the President Corporate Profile / Access ∟Mitsubishi Chemical Group Corporation ∟Mitsubishi Chemical Corporation ∟Mitsubishi Tanabe Pharma Corporation ∟Nippon Sanso Holdings Corporation Leadership Organization Chart Global Network Number of Subsidiaries History Corporate Brochure Evaluation by Outside Parties Approach to Corporate Activities Group Concept Charter of Corporate Behavior Value Creation Model Health and Productivity Management Management Strategy Management Policy Business Strategy ∟Specialty Materials ∟Industrial Gases ∟Health Care ∟MMA ∟Petrochemicals and Carbon Products Governance Corporate Governance ∟Corporate Governance Guidelines Risk Management Compliance Media KAITEKI Solution Center  Digital Showroom  Social Media ∟LinkedIn account  ∟X account  ∟YouTube channel  Products Innovation Innovation CTO Message --> Innovation Strategy Intellectual Property Strategy Mitsubishi Chemical Corporation R&D Main R&D Organization Award History Paper Submission Investors Investors Management Policy Message from the President --> Management Policy Disclosure Policy IR News IR News TSE Filings Basic Information Chart IR Calendar Financial Data ∟Financial Highlight ∟Historical DATA  Evaluation by Outside Parties (ESG) Other IR Information ∟FAQ on IR ∟Contact on IR ∟IR Sitemap IR library Financial Results Operating Summaries Analysts Meeting Materials Integrated Reports Securities Reports Report in Line with the Recommendations of the TCFD To Our Individual Investors The Mitsubishi Chemical Group in Numbers Stock and Bond Information ∟Stock Information ∟Dividend ∟Shareholders Meeting ∟Articles of Incorporation ∟Ratings and Bonds Sustainability Sustainability Sustainability Activities Sustainability Approach and Promotion Structure Material Issues and　Sustainability(MOS) Indices​ ESG Initiatives Environment Social Governance Sustainability Data Sustainability (MOS) Results Non-Financial Data Sheets GRI Standards Integrated report "KAITEKI Report" News News Releases Information IR News TSE Filings Contact Us 日本語 English 中文 --> --> --> --> HOME News Releases 2024 News Releases 2024 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 May 15, 2024 Financial Results Consolidated Financial Results for the Fiscal Year Ended March 31, 2024 (Under IFRS)NEW May 9, 2024 Business Lawson Selects BENEBiOL, a Biomass-based Polycarbonatediol, for New Store in Aomori Prefecture, JapanNEW May 9, 2024 Business The Global Health Innovative Technology Fund provides grant to Mitsubishi Tanabe Pharma and DNDi for Chagas disease drug discoveryNEW May 8, 2024 Business Asahi Kasei, Mitsui Chemicals, and Mitsubishi Chemical to start joint feasibility study on carbon neutrality of ethylene production facilities in western Japan May 8, 2024 Business Announcement of Approval Submission and Marketing Alliance in Japan for Tirzepatide as a Drug for Obesity Disease May 7, 2024 Business Santen and Mitsubishi Tanabe Pharma announce the conclusion of a contract for the joint sales promotion in Japan of Alesion® Eyelid Cream 0.5%, a new treatment for allergic conjunctivitis Apr. 25, 2024 Others Notice Regarding Delivery of Restricted Shares to Corporate Executive Officers and Executive Officers Apr. 12, 2024 Business Components with Compliant Mechanism Design Adopted for Lunar Rover YAOKI Apr. 9, 2024 Business RADICAVA ORS® as Orphan drug designation and approval in US Apr. 2, 2024 Business Biomass-based Polycarbonatediol “BENEBiOL” Adopted for the Watch Band of Citizen Watch Apr. 1, 2024 Others Message from Manabu Chikumoto, Representative Corporate Executive Officer, President and Chief Executive Officer of Mitsubishi Chemical Group Corporation,for 2024 Career Kick-off Session (Summary) Apr. 1, 2024 Others Greeting from Manabu Chikumoto, new Representative Corporate Executive Officer, President and Chief Executive Officer of Mitsubishi Chemical Group Corporation (Summary) Mar. 25, 2024 Business The Mitsubishi Chemical Group’s Initiatives to Combat the Year 2024 Problem as a Chemical Manufacturer, Which Is a Starting Point of Manufacturing, Towards Building a Sustainable Supply Chain Mar. 22, 2024 Personnel Announcement of Personnel Change of the Mitsubishi Chemical Group Mar. 21, 2024 Others Main building of Mitsubishi Chemical Group's Science & Innovation Center receives WELL Building Standard v2 pilot certification Mar. 19, 2024 Business Announcement of Publication in The Lancet Neurology from the Clinical Study of Investigational ND0612 for Parkinson's Disease Mar. 18, 2024 Business Nichigo G-Polymer, a special brand of polyvinyl alcohol, certified as a recyclable material for polyethylene-based multilayer packaging materials in Europe Mar. 18, 2024 Business Additional Approval of SGLT2 inhibitor CANAGLU® OD Tablets～First OD Tablets of SGLT2 inhibitors in Japan～ Mar. 15, 2024 Business Launch of "GOBIK Aqueous Suspension Syringes", Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine Mar. 13, 2024 Business Mitsubishi Chemical Group announces the Winner of the 3D Printing FGF Engineering Challenge Mar. 12, 2024 Others Notice Concerning Change of Major Shareholder Mar. 12, 2024 Business Mitsubishi Chemical Group Develops BiOpreg #400 Series Carbon Fiber Prepreg Using Plant-Derived Resin Mar. 4, 2024 Business Expiration of Marketing Alliance Agreement for TENELIA® Tablets, TENELIA® OD Tablets and CANAGLU® Tablets Mar. 1, 2024 Business Mitsubishi Chemical Group to increase Sugar Ester emulsifier production capacityWill add new line to Kyushu Plant to meet global demand for high-quality food products Feb. 27, 2024 Personnel Announcement of Organizational Changes and Personnel Changes of the Mitsubishi Chemical Group Feb. 27, 2024 Business Announcement on the Discontinuance of MMA Production by the ACH Process and Acrylonitrile-Related Production at the Hiroshima Plant, and on Subsequent Withdrawal from Some Businesses Feb. 27, 2024 Business Launch of Radicava® for the Treatment of ALS in Brazil～First successful launch by a partner in global expansion～ Feb. 22, 2024 Personnel Notice Regarding Change (Appointed) of Representative Corporate Executive Officer Feb. 20, 2024 Business Application for Additional Dosage Form of CANALIA® Combination OD Tablets, Selective DPP-4 inhibitor/SGLT2 inhibitor Combination Drug Feb. 14, 2024 Business Mitsubishi Chemical Group Develops Carbon Fiber-based 1,500 °C Heat-Resistant Ceramic Matrix Composite (C/SiC) Feb. 14, 2024 Business Plant-derived bioengineering plastic DURABIO used in Sunstar’s Ora2 Toothbrush Feb. 13, 2024 Others Signed a Comprehensive Collaboration Agreement with Fukui Prefecture to Build a Sustainable Society Feb. 9, 2024 Business Newly Developed Biodegradable Biopolyester Resins- High biomass content, flexibility, high tear strength, and excellent processability - Feb. 8, 2024 Personnel Notice Regarding Change (Retirement) of Representative Corporate Executive Officer Feb. 8, 2024 Personnel Announcement of Organizational Changes and Personnel Changes of the Mitsubishi Chemical Group Feb. 7, 2024 Business Developed “NOVADURAN ZR Series” Foaming Polybutylene Terephthalate Resin- Enables the production of molded products with ultra-low specific gravity less than 1.0 in a simple process - Feb. 6, 2024 Financial Results Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2024 (Under IFRS) Jan. 29, 2024 Business Transfer of Three Marketed Products in Japan Jan. 26, 2024 Business Mitsubishi Chemical Group to Commence Full-fledged Verification Testing for the World’s First Commercialization of Polycarbonate Resin Chemical Recycling Conducting testing for collecting polycarbonate resin from headlamps of end-of-life vehicles in collaboration with Tokio Marine & Nichido and ABT Jan. 26, 2024 Business Mitsubishi Tanabe Pharma contribute funding to Global Health Innovative Technology Fund's third phase ―Targeting treatments for infectious diseases that burden the developing world― Jan. 25, 2024 Business Plant-derived Bioengineering Plastic DURABIO Selected by Panasonic for Wireless Earphones Jan. 23, 2024 Business Co-promotion of "GOBIK Aqueous Suspension Syringes", Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine Jan. 4, 2024 Others New Year Message from President and CEO, Jean-Marc Gilson (summary) ・Information is current as of the date of issue of the individual press release. Please be advised that information may be outdated after that point. ・Some of news releases issued by The Mitsubishi Chemical Group cover information related to pharma businesses. Disclosure of information on ethical drugs and developments is for the purpose of providing information to the press, etc., and is not for the purpose of promotion, advertising, or medical advice. Corporate Information Corporate Information Corporate Information Basic Information Message from the President Corporate Profile / Access ∟Mitsubishi Chemical Group Corporation ∟Mitsubishi Chemical Corporation ∟Mitsubishi Tanabe Pharma Corporation ∟Nippon Sanso Holdings Corporation Leadership Organization Chart Global Network Number of Subsidiaries History Corporate Brochure Evaluation by Outside Parties Approach to Corporate Activities Group Concept Charter of Corporate Behavior Value Creation Model Health and Productivity Management Management Strategy Management Policy Business Strategy ∟Specialty Materials ∟Industrial Gases ∟Health Care ∟MMA ∟Petrochemicals and Carbon Products Governance Corporate Governance ∟Corporate Governance Guidelines Risk Management Compliance Media KAITEKI Solution Center Digital Showroom Social Media ∟LinkedIn account  ∟X account  ∟YouTube channel  Business・Products Business・Products Innovation Innovation Innovation CTO Message --> Innovation Strategy Intellectual Property Strategy Mitsubishi Chemical Corporation R&D Main R&D Organization Award History Paper Submission Investor Relations Investor Relations Investor Relations Management Policy Message from the President --> Message from the CFO --> Outside Directors’ Discussion Meeting --> Management Policy Disclosure Policy IR News IR News TSE Filings Basic Information Chart IR Calendar Financial Data Evaluation by Outside Parties (ESG) Other IR Information ∟FAQ on IR ∟Contact on IR ∟IR Sitemap IR library Financial Results Operating Summaries Analysts Meeting Materials Integrated Reports Securities Reports Report in Line with the Recommendations of the TCFD To Our Individual Investors The Mitsubishi Chemical Group in Numbers Stock and Bond Information Sustainability Sustainability Sustainability Sustainability Activities Sustainability approach and promotion structure Material Issues and Sustainability(MOS) Indices ESG Initiatives Environment Society Governance Sustainability Data Sustainability (MOS) results Non-Financial Data Sheets GRI Standards KAITEKI Solution Center News Releases Information Digital Showroom Contact Us FAQ The Mitsubishi Chemical Group Official Accounts Sitemap Terms of Use Privacy Policy Social Media Terms of Use Copyright © Mitsubishi Chemical Group Corporation.